Navigation Links
Labopharm Reaquires UK Sales And Marketing Rights to Its Once-Daily Tramadol Product
Date:7/7/2008

c.

Labopharm is an emerging leader in optimizing the performance of existing small molecule drugs using its proprietary controlled-release technologies. The Company's lead product, a unique once-daily formulation of tramadol, is being commercially launched in key markets globally. The Company also has a robust pipeline of follow-on products in both pre-clinical and clinical development. Labopharm's vision is to become an integrated, international, specialty pharmaceutical company with the capability to internally develop and commercialize its own products. For more information, please visit http://www.labopharm.com.

This press release contains forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual events could differ materially from those projected herein and depend on a number of factors, including the uncertainties related to the regulatory process in various countries for the approval of the Company's products and the successful commercialization of the products throughout the world if they are approved. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements.


'/>"/>
SOURCE Labopharm Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
2. Labopharm provides update on U.S. regulatory process for once-daily Tramadol
3. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
4. Labopharm appeals FDAs decision on once-daily tramadol
5. Labopharm to host conference call Friday, November 9, 2007 at 8:30 a.m. (ET)
6. Labopharm to present at CIBC World Markets 18th Annual Healthcare Conference
7. Labopharm Reports Results for Third Quarter Fiscal 2007
8. Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol
9. Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova
10. Canadian Marketing and Sales Effort for Labopharms Once-Daily Tramadol Product to Expand Significantly
11. Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... Rare Genomics Institute (RG) today ... at determining how crowdfunding can promote scientific research to ... providing rare disease patients with access to state of ... researchers, and help for payment of these services through ... see how crowdfunding will not only help raise much ...
(Date:5/5/2015)... May 05, 2015 With Mother's ... Organics, one of the country's leading organic vegetable ... of moms across the country. What to eat? ... recipe box or spend hours browsing Pinterest – ... http://www.josiesorganics.com/recipes . , The new recipes ...
(Date:5/5/2015)... What do you get when you combine ... greatest mountaineers and one of the world’s greatest causes? The ... documentary by Marc Middleton, which follows world-renowned mountaineer Chris Warner ... 19,341-foot frozen summit of Mount Kilimanjaro. , “This film ... to action. Viewers are moved to ask, ‘What can I ...
(Date:5/5/2015)... 2015 Specialty makeup brand ... Eagle Outfitters on a collection of summer-oriented cosmetics ... , For the debut five-piece summer collection, Beauty ... American Eagle ; the retailer's fast-growing intimates, swim ... "Aerie REAL," uses models of various sizes and ...
(Date:5/5/2015)... NovaSom, Inc., announced today that they will ... Ed Begley Jr., airing via Discovery Channel 3rd QTR ... will focus on NovaSom, a leader in Obstructive Sleep ... AccuSom® home sleep test, which is the only comprehensively ... and next-day test results and interpretation. , ...
Breaking Medicine News(10 mins):Health News:Rare Genomics Institute to Study Impact of Crowdfunding on Rare Diseases 2Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 2Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 3Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 4Health News:LIVESTRONG & Bolder Broadcasting Present Special Edition of Conquering Kilimanjaro 2Health News:LIVESTRONG & Bolder Broadcasting Present Special Edition of Conquering Kilimanjaro 3Health News:BLKBOXLabs Finds Real Beauty in Beauty For Real and American Eagle Outfitters’ Aerie-Branded Beauty Line 2Health News:BLKBOXLabs Finds Real Beauty in Beauty For Real and American Eagle Outfitters’ Aerie-Branded Beauty Line 3Health News:Innovations with Ed Begley, Jr. to Explore NovaSom, Inc., in Upcoming Episode 2
... University School of Medicine have devised a software algorithm that ... whole-blood sample into its different cell types and detect medically ... types. In a study to be published online March ... they had successfully used the new technique to pinpoint changes ...
... it that much harder to eliminate, scientists say , SUNDAY, ... of the AIDS virus in the blood to zero, but ... taking their pills. Now, research is giving scientists new insight ... killing powers of medicine. , In a new study, ...
... , ... the work of two St. Elizabeth Internal Medicine residents in hypertension therapy and sleep ... , ... (Vocus) March 7, 2010 -- In April, the work of two St. Elizabeth Internal ...
... ... line of quick couplings and plastic fittings are all designed, tooled, manufactured, sold, assembled, ... ... their Made in the USA Brand certification. Their revolutionary line of quick couplings ...
... ... Announces Sponsors for the 2010 Cinco de Mayo Half Marathon and the 12th Annual “Reaching ... ... The Pediatric Cancer Research Foundation (PCRF) announced the official sponsors for the annual “Reaching ...
... ... team, adding certified fitness specialist-expert and nutritionist counselor, Rod Stanley, to give patients 1:1 ... ... national healthy aging expert and age management medicine icon, is boosting patient motivational ...
Cached Medicine News:Health News:Mathematical innovation turns blood draw into information gold mine in Stanford study 2Health News:Mathematical innovation turns blood draw into information gold mine in Stanford study 3Health News:Mathematical innovation turns blood draw into information gold mine in Stanford study 4Health News:HIV Hides Out in Bone Marrow Cells 2Health News:St. Elizabeth Medical Residents to Present Research at International Meeting, 2Health News:Kent Systems Received Made in the USA Brand Certification 2Health News:Sponsors for the 2010 Pediatric Cancer Research Foundation “Reaching for the Cure” Annual Cinco de Mayo Run/Walk Fundraising Event 2Health News:Sponsors for the 2010 Pediatric Cancer Research Foundation “Reaching for the Cure” Annual Cinco de Mayo Run/Walk Fundraising Event 3Health News:Healthy Aging Icon Ups Patient Motivational Levels, Signs His Personal Trainer To Age-Management Team 2Health News:Healthy Aging Icon Ups Patient Motivational Levels, Signs His Personal Trainer To Age-Management Team 3
(Date:5/5/2015)... Research and Markets ( http://www.researchandmarkets.com/research/79lcd4/will_theranos ) ... Turn the Lab Industry Upside Down?" report to ... along with a healthy dose of skepticism in recent ... disruptive laboratory solution. Behind all of the press, there ... microfluidic technology across a comprehensive menu of tests? ...
(Date:5/4/2015)... Luminex Corporation (NASDAQ: LMNX ) today announced financial results ... operating highlights include the following: , Consolidated first ... the first quarter of 2014. , First quarter assay ... first quarter of 2014. , Consolidated gross profit margin ... , GAAP net income for the first quarter was $7.5 ...
(Date:5/4/2015)... , May 4, 2015  Neurocrine Biosciences, Inc. (NASDAQ: ... Aurora has joined the company as Vice President, ... to welcome Dr. Bill Aurora to the ... Kevin Gorman , President and Chief Executive Officer ... scientific exchange and outreach coupled with his extensive network ...
Breaking Medicine Technology:Will Theranos Turn the Lab Industry Upside Down? 2Luminex Corporation Reports First Quarter 2015 Results 2Luminex Corporation Reports First Quarter 2015 Results 3Luminex Corporation Reports First Quarter 2015 Results 4Luminex Corporation Reports First Quarter 2015 Results 5Luminex Corporation Reports First Quarter 2015 Results 6Luminex Corporation Reports First Quarter 2015 Results 7Luminex Corporation Reports First Quarter 2015 Results 8Luminex Corporation Reports First Quarter 2015 Results 9Luminex Corporation Reports First Quarter 2015 Results 10Luminex Corporation Reports First Quarter 2015 Results 11Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs 2Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs 3
... 2011 MedCath Corporation (Nasdaq: MDTH ) will ... 9, 2011 to announce results from its first fiscal quarter ... not to host a conference call to review its first ... Charlotte, N.C., is a healthcare provider focused on high acuity ...
... ThermoGenesis Corp. (Nasdaq: KOOL ), a leading ... store adult stem cells, and TotipotentSC, a U.S. company ... therapy and clinical research management, announced today they have ... Committee to proceed with a Phase Ib clinical trial ...
Cached Medicine Technology:ThermoGenesis Corp. and TotipotentSC Receive Approval for Phase Ib Clinical Trial of Res-Q™ 60 BMC for Treatment of Critical Limb Ischemia 2ThermoGenesis Corp. and TotipotentSC Receive Approval for Phase Ib Clinical Trial of Res-Q™ 60 BMC for Treatment of Critical Limb Ischemia 3ThermoGenesis Corp. and TotipotentSC Receive Approval for Phase Ib Clinical Trial of Res-Q™ 60 BMC for Treatment of Critical Limb Ischemia 4
White Standard Girdle...
Black Spandex Above the Knee Compression Girdles with Contact Closure with Zipper...
Short Girdle, Mid-thigh, Front Closure...
Male Body Shaper, Front Closure...
Medicine Products: